Finally, CD133+ LMPC xenografts developed abnormal lymphatic vessels that expressed podoplanin, LYVE1, Prox1 and VEGFR-3, similar to patterns observed in LM patient tissues and CD133− LMEC xenografts. The gene discussed is PROX1; the disease is lymphangioma.